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Abstract
 
Interleukin 12 (IL-12) is a 70-kD proinflammatory cytokine produced by antigen presenting
cells that is essential for the induction of T helper type 1 development. It comprises 35-kD
(p35) and 40-kD (p40) polypeptides encoded by separate genes that are induced by a range of
stimuli that include lipopolysaccharide (LPS), DNA, and CD40 ligand. To date, the regulation
of IL-12 expression at the transcriptional level has mainly been examined in macrophages and
restricted almost exclusively to the 
 
p40
 
 gene. Here we show that in CD8
 
 
 
 dendritic cells, ma-
jor producers of IL-12 p70, the Rel/nuclear factor (NF)-
 
 
 
B signaling pathway is necessary for
the induction of IL-12 in response to microbial stimuli. In contrast to macrophages which re-
quire c-Rel for 
 
p40
 
 transcription, in CD8
 
 
 
 dendritic cells, the induced expression of 
 
p35
 
 rather
than 
 
p40
 
 by inactivated 
 
Staphylococcus aureus
 
, DNA, or LPS is c-Rel dependent and regulated
directly by c-Rel complexes binding to the 
 
p35
 
 promoter. This data establishes the IL-12 p35
gene as a new target of c-Rel and shows that the regulation of IL-12 p70 expression at the
transcriptional level by Rel/NF-
 
 
 
B is controlled through both the p35 and p40 genes in a cell
type–specific fashion.
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Introduction
 
IL-12 is a disulfide-linked 70-kD heterodimer composed of
35-kD (p35) and 40-kD (p40) subunits, each of which is
encoded by a distinct gene (1). IL-12 p70 is important in
the immune response to microorganisms and tumors, acti-
vating NK cells and T lymphocytes, which in turn initiates
IFN-
 
 
 
 production and antigen-specific Th1 responses (1–
3). Its role in promoting inflammation has also led to IL-12
being implicated in immunopathology associated with al-
lergy and autoimmune diseases (1).
Although many different APCs produce IL-12 (1), den-
dritic cells (DCs)
 
*
 
 have emerged as major producers of this
cytokine both in culture and in vivo in response to stimuli
 
of a
 
 
 
microbial origin, or a T cell–derived signal such as
CD40 ligand (4–7). The regulation of IL-12 production is
complex, with evidence for the control of p35 and p40 ex-
pression at the transcriptional, posttranscriptional, and post-
translational levels (1). To date, the regulation of IL-12 ex-
pression has largely focused on p40. This is largely the
result of early findings that showed the induction of IL-12
coincided with an upregulation of p40 mRNA levels,
while 
 
p35
 
 gene expression was generally ubiquitous (1).
Recent evidence, however, suggests that attributing the in-
duced expression of IL-12 solely to an increase in p40 ex-
pression is an oversimplification. First, the level of p35
mRNA is rapidly elevated in monocytes and DCs by the
same agents that induce p40 expression and IL-12 produc-
tion (8, 9). Second, p40 is frequently produced in excess as
a monomer or a homodimer (p40)2 (1, 10, 11). As p40 ho-
modimers bind to the IL-12 receptor and antagonize IL-12–
mediated immune function (12), the biological activity of
IL-12 may be determined in part by the ratio of p70 to
(p40)2, which in turn would indicate that p35 levels are
 
R. Grumont and H. Hochrein contributed equally to this work.
H. Hochrein’s present address is Medical Microbiology, Department of
Immunology and Hygiene, Technical University of Munich, Munich
D-81675, Germany.
Address correspondence to S. Gerondakis, The Walter and Eliza Hall
Institute of Medical Research, Post Ofﬁce The Royal Melbourne
Hospital, Victoria 3050, Australia. Phone: 61-3-93452542; Fax: 61-3-
93470852; E-mail: gerondakis@wehi.edu.au
 
*
 
Abbreviations used in this paper:
 
 DC, dendritic cell; EMSA, electro-
phoretic mobility shift assay; NF, nuclear factor; SAC, 
 
Staphylococcus aureus
 
. 
1022
 
c-Rel Regulation of IL-12 p35 Transcription
 
likely to be an important limiting factor in determining IL-
12 production. This later point is consistent with the ca-
pacity of IL-4 to simultaneously increase p35 mRNA and
IL-12 levels in DCs in response to microbial stimuli, while
downregulating p40 mRNA and protein expression (13).
Among those transcription factors implicated in the con-
trol of IL-12 gene expression, Rel/nuclear factor (NF)-
 
 
 
B
proteins, in particular c-Rel has been shown to be impor-
tant for LPS-induced p40 transcription in macrophages (14,
15). Rel/NF-
 
 
 
B transcription factors are homodimeric and
heterodimeric proteins composed of related polypeptides
that are encoded by a multigene family (16). The mamma-
lian subunits (c-Rel, RelA, RelB, NF-
 
 
 
B1, and NF-
 
 
 
B2)
share a conserved NH
 
2
 
-terminal domain that encompasses
sequences required for DNA binding, dimerization, and
nuclear localization (16). c-Rel, RelA, and RelB each pos-
sess COOH-terminal transcriptional transactivation do-
mains. In contrast, the proteolytically processed 50- and
52-kD forms of NF-
 
 
 
B1 and NF-
 
 
 
B2, respectively, lack
intrinsic transactivating properties and instead function as
homodimeric repressors or modulators of the transactivat-
ing dimer partners (16). In most cells, Rel/NF-
 
 
 
B factors
are retained in the cytoplasm as an inactive complex with
inhibitor or I
 
 
 
B proteins (17). Diverse signals induce the
nuclear translocation of Rel/NF-
 
 
 
B by activating an I
 
 
 
B
kinase complex that phosphorylates the I
 
 
 
B proteins, tar-
geting them for ubiquitin-dependent proteosome-medi-
ated degradation (17, 18). Upon translocation to the nu-
cleus, Rel/NF-
 
 
 
B proteins regulate gene expression by
binding to specific sequences (
 
 
 
B elements) located within
the transcriptional regulatory regions of cellular genes, par-
ticularly those encoding proteins involved in immune,
acute phase, and inflammatory responses (16).
Although Rel/NF-
 
 
 
B regulation of IL-12 expression
has been studied most extensively in macrophages and
monocytic cell lines (1, 8, 14, 15, 19), the critical function
DCs serve in initiating antigen-dependent T cell responses
(2–6), prompted us to examine what role the Rel/NF-
 
 
 
B
pathway has in controlling IL-12 expression in these APCs.
Here we show using mice that lack various individual
members of the Rel/NF-
 
 
 
B family, that in CD8
 
 
 
 splenic
DCs the rapid upregulation of IL-12 in response to micro-
bial stimuli is dramatically reduced in the absence of c-Rel.
In contrast to previous findings for 
 
c-rel
 
 
 
/
 
 
 
 macrophages
that show an inability to upregulate IL-12 coincided with a
failure to induce p40 transcription (15), in CD8
 
 
 
 DCs this
defect is primarily due to impaired 
 
p35
 
 gene expression.
Consistent with this finding, we also establish that the 
 
p35
 
gene is a direct transcriptional target of c-Rel.
 
Materials and Methods
 
Mice.
 
C57BL/6 mice were bred under specific pathogen free
conditions in the animal facility of The Walter and Eliza Hall In-
stitute. The generation of 
 
c-rel
 
 
 
/
 
 
 
 (20), 
 
nfkb1
 
 
 
/
 
 
 
 (21), and 
 
rela
 
 
 
/
 
 
 
mice (22) has been described previously. All mutant mouse strains
have been backcrossed for eight or more generations with
C57BL/6 mice.
 
Cytokines, Antibodies, and Reagents.
 
Murine rGM-CSF and
rIL-4 were gifts from Immunex Corp. Rat rIFN-
 
 
 
 (bioactive in
mouse) was purchased from PeproTech. Murine rIL-12 p70 and
murine rIL-12 (p40)
 
2
 
 were purchased from R&D Systems. Flt-3
ligand (Flt-3L) was produced from the CHO-flk2 cell line pro-
vided by N. Nicola (The Walter and Eliza Hall Institute). Pan-
sorbin (fixed and heat killed 
 
Staphylococcus aureus
 
 [SAC]) was pur-
chased from Calbiochem-Novabiochem, and lipopolysaccharide
was obtained from Difco. An oligonucleotide containing a CpG
motif (CpG) was synthesized by GeneWorks according to a pub-
lished sequence (CpG1668). The fluorescence-conjugated anti-
body used for selecting DC was FITC-conjugated anti-CD11c
(N418). Monoclonal antibodies were purified and labeled as pub-
lished elsewhere (23, 24).
 
Mouse DC Preparation.
 
DCs were extracted from mouse
spleens as described (23). In brief, organs were chopped, digested
with collagenase, treated with EDTA, and light density cells col-
lected by density centrifugation. Non-DC lineage cells were de-
pleted by coating them with a mixture of monoclonal antibodies
and then removing the coated cells with magnetic beads coupled
to anti–rat-IgG (24). The DC enriched preparations were then
stained with an anti–CD11c-FITC conjugated mAb. Propidium
iodide (PI) was added in the final wash to label dead cells. For cy-
tometric sorting, the cells were gated for DC characteristics,
namely high forward and side scatter plus bright staining for
CD11c, with PI-labeled cells excluded. The purity of the sorted
DCs was typically 
 
 
 
98%.
 
Stimulation of DCs in Culture for IL-12 Production.
 
Sorted splenic
mouse DCs (10
 
5
 
) were cultured in 96-well round bottom plates
in a final volume of 200 
 
 
 
l with an IL-12 stimulus (250 nM CpG
DNA, 5 to 20 
 
 
 
g/ml of SAC, or 1 
 
 
 
g/ml of LPS) in the pres-
ence of IL-4 (100 U/ml or titrated), GM-CSF (200 U/ml or ti-
trated), and IFN-
 
 
 
 (20 ng/ml or titrated). After 18 h of culture,
the supernatant was collected, separated from cells by centrifuga-
tion, and stored at 
 
 
 
70
 
 
 
C before analysis.
 
IL-12 Polypeptide Analysis by Western Blotting.
 
Aliquots of DC
culture supernatants were subjected to SDS-PAGE (9% acryl-
amide) under non-reducing conditions. The electrophoresed
proteins were transferred onto Immobilon-P membrane (Milli-
pore) according to the manufacturer’s instructions. Membranes
were blocked with 5% BSA in PBS overnight at 4
 
 
 
C. IL-12
polypeptides were detected by incubation with biotinylated
C17.8 (anti–IL-12 p40) monoclonal antibody (0.5 
 
 
 
g/ml in 1%
BSA, 0.05% Tween 20 in PBS) for 1 h at 4
 
 
 
C, followed by incu-
bation with streptavidin-horseradish peroxidase conjugate (Amer-
sham LifeScience) dilution in 1% BSA, 0.05% Tween 20 in PBS
for 1 h at 4
 
 
 
C. Membranes were then developed with Supersignal
West Pico Chemiluminescent Substrate (Pierce Chemical Co.),
according to the manufacturer’s instructions.
 
Analysis of Mouse IL-12 by ELISA.
 
Aliquots of DC culture
supernatants were assayed by two site ELISA. In brief, 96-well
polyvinyl chloride microtiter plates (Dynatech Laboratories) were
coated with the appropriate purified capture mAb, namely R2-
9A5 (anti–mouse IL-12 p70; American Type Culture Collection)
or C15.6 (anti–mouse IL-12 p40; BD PharMingen). Cytokine
binding was then detected with an appropriate biotinylated de-
tection mAb, namely R1-5D9 (anti–mouse IL-12 p40, American
Type Culture Collection) or C17.8 (anti–mouse IL-12 p40, hy-
bridoma provided by L. Schofield, The Walter and Eliza Hall In-
stitute). The readout was obtained using streptavidin-horseradish
peroxidase conjugate (Amersham Pharmacia Biotech) and a sub-
strate solution containing 548 
 
 
 
g/ml ABTS (2,2
 
 
 
-Azino-
bis(3-ethylbenz-thiazoline-6-sulfonic acid)) (Sigma-Aldrich) and 
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0.001% hydrogen peroxide (Ajax Chemicals) in 0.1 M citric acid,
pH 4.2, which was scanned at an optical density of 405–490 nm.
As the mouse IL-12 p40 ELISA also detects mouse IL-12 p70,
p40 and (p40)2 levels were determined by subtracting the amount
of mouse IL-12 p70 obtained with the mouse IL-12 p70 ELISA
from values obtained with the mouse IL-12 p40 ELISA.
 
Northern Analysis of IL-12 p40 and p35 mRNA Expression.
 
For Northern blot analysis, groups of three mice were treated
with Flt3-L (10 
 
 
 
g/day for 10 d) and the splenic DCs then iso-
lated as described above. The administration of Flt3-L to C57BL/6
mice greatly enhances the number of splenic DCs (by 
 
 
 
30-
fold) without altering their IL-12 expression (25). Cultures of
these DCs (13 
 
 
 
 10
 
6
 
 DCs/5 ml culture) were stimulated for 4 h
with DNA (0.5 
 
 
 
M) or LPS (1 
 
 
 
g/ml) in the presence of IFN-
 
 
 
(20 ng/ml) and IL-4 (50 U/ml). Total RNA isolated from ap-
proximately 2 
 
 
 
 10
 
6
 
 DCs using RNAagents (Promega) was frac-
tionated on 1% formaldehyde-agarose gels and transferred onto
Hybond-C membranes (Amersham LifeScience). Filters were
baked, prehybridized in 50% formamide, 5
 
  
 
SCC, 0.02% Ficoll,
0.02% polyvinylpyrrolidine, 0.02% albumin, 500 
 
 
 
g/ml of dena-
tured herring sperm DNA, and hybridized for 18 h at 42
 
 
 
C with
radiolabeled probes at a concentration of 2 
 
 
 
 10
 
6
 
 cpm/ml. Filters
were washed in 0.2
 
 
 
 SCC, 0.1% SDS at 65
 
 
 
C and exposed to
autoradiography at 
 
 
 
70
 
 
 
C. For successive hybridizations, filters
were first boiled in 10 mM EDTA, 0.1% SDS to remove bound
probe. The probes used were a 1.0-kb EcoRI-HindIII murine
p40 cDNA (13), a 0.66-kb EcoRI-KpnI fragment derived by
PCR from the murine p35 cDNA (13), and a 1.1-kb PstI rat
glyceraldehyde-3-phosphatedehydrogenase cDNA (26) insert.
Probes were radiolabeled by random primer extension with
[
 
 
 
-
 
32
 
P]dATP to specific activities ranging between 5 
 
 
 
 10
 
8
 
 and
10
 
9
 
 cpm/
 
 
 
g.
 
Genomic Clones and Plasmid Constructs.
 
A 62-bp genomic
clone encompassing nucleotides 
 
 
 
425 to 
 
 
 
196 of the murine IL-
12 
 
p35
 
 gene (27) was isolated by PCR from C57BL6 liver ge-
nomic DNA and characterized by automated sequencing. This
fragment was inserted into the promoterless reporter plasmid
pA3luc (28) and designated p35
 
 
 
B-luc. The plasmid p35
 
 
 
B
 
m
 
-luc
is a derivative of p35
 
 
 
B-luc in which the Rel/NF-
 
 
 
B binding
site (5
 
 
 
-GGGAATCCC-3
 
 
 
) at 
 
 
 
63 to 
 
 
 
54 (27) was altered by in
vitro mutagenesis (29).
 
Transfections and Luciferase Assays.
 
The J774 and A7L.13 cell
line (30) were transiently transfected using Superfect (QIAGEN)
as described previously (31). Equimolar amounts (1–2 
 
 
 
g) of the
 
p35 
 
promoter reporter plasmids were transfected alone or with a
threefold molar excess (10–12 
 
 
 
g) of the expression plasmids
pDAMP56 or pDAMP56c-rel (32). Approximately 48 h later,
transfected cells were harvested and luiferase assays performed on
cell extracts that had been standardized for equivalent protein
content. Transfections were performed five times, with a maxi-
mum variance of approximately 15% observed between replicate
experiments.
Electrophoretic Mobility Shift Assays. The p35 B probe was
prepared by end-labeling the double stranded oligonucleotide
5 -GTTACCCCACTGGGAATCCCTTCAGCCACC-3  and
electrophoretic mobility shift assay (EMSA) reactions performed
with 1–2  g of nuclear extract as described previously (33). For
competition analysis, a 50-fold excess of unlabeled p35 B
or p35 Bm (5 -GTTACCCCACTGTCAATAACTTCAGCCA-
CC-3 ) competitor DNA was added to the reaction at room
temperature for 15 min before addition of the radiolabeled probe.
For supershift analysis, antibodies that specifically recognize NF-
 B1 (sc1192; Santa Cruz Biotechnology, Inc.), c-Rel (33), RelA
(sc109), RelB (sc226), or NF- B2 (sc298) were incubated with
nuclear extracts on ice for 30 min. before adding radiolabeled
probe. All EMSA reactions were incubated for 20 min at room
temperature, 2  l of Ficoll dye was added, and the reactions were
fractionated on 5% nondenaturing polyacrylamide gels. Gels were
then dried and exposed to autoradiography at  70 C.
Semiquantitative Reverse Transcription PCR. Total RNA was
isolated using RNAgents (Promega) from the cell line A7L.13
(106 cells) that were untreated or stimulated for 4 h with LPS (1
 g/ml) or CpG DNA (250 nM). cDNA synthesis on equivalent
amounts of total RNA was performed essentially as described
(31). For semiquantitative PCR, cDNA was added to a cocktail
comprising 50 mM KCl, 2 mM MgCl2, 10 mM Tris-HCl, pH
8.3, 0.01% (wt/vol) gelatin, 0.5 mM dNTPs, 1 U of Taq poly-
merase, and 1  M of each oligonucleotide in a final volume of 50
 l. After an initial 5-min denaturation at 94 C, the cDNA was
amplified for 25 cycles with each cycle programmed for denatur-
ation at 94 C for 45 s, annealing at 58 C for 60 s, followed by
elongation at 72 C for 90 s. Samples were then fractionated on a
1% agarose gel. The sequence of the oligonucleotides used for the
amplification of murine p35, p40, and  -actin mRNA were: p35
(forward, ATGATGACCCTGTGCCTTGG; reverse, CCT-
TTGGGGAGATGAGATGT; product size 448 bp), p40 (for-
ward, AACCTCACCTGTACACGCC; reverse CAAGTC-
CATGTTTCTTTGCACG; product size 309 bp), and  -actin
(forward, CTGAAGTACCCATTGAACATGGC; reverse, CA-
GAGCAGTAATCTCCTTCTGCAT; product size 726 bp).
Results
c-Rel Is Essential for Induced Expression of IL-12 by CD8 
DCs. To determine what role Rel/NF- B transcription
factors serve in regulating IL-12 expression by activated
DCs, we used mutant mice that lacked either c-Rel, NF-
 B1, or RelA. Equivalent numbers of purified splenic
CD11c  DCs isolated from c-rel /  and nfkb1 /  mice, or
lethally irradiated C57BL/6Ly5.1  recipients engrafted
with E13 rela /  fetal liver hemopoietic progenitors were
stimulated in culture for 18 h with SAC or unmethylated
DNA containing CpG motifs in the presence of a cytokine
cocktail (IL-4, IFN- , and GM-CSF) previously shown to
enhance IL-12 expression (13). Levels of p40, (p40)2, and
IL-12 p70 secreted into culture supernatants were then
measured by ELISA using anti–p40– and anti-p70–specific
antibodies (Fig. 1). While the amount of IL-12 (Fig. 1 A)
produced by activated rela /  (Fig. 1 A, lanes 7 and 11) and
nfkb1 /  (Fig. 1 A, lanes 8 and 12) DCs was only two and
fourfold lower respectively than that secreted by wild-type
cells (Fig. 1 A, lanes 5 and 9), IL-12 levels were reduced
30- to 50-fold in the c-rel /  DC cultures (Fig. 1 A, lanes 6
and 10). As this reduction in IL-12 was observed for DNA
and SAC stimulated c-rel /  DCs, with the relative levels of
IL-12 secreted by wild-type and c-rel /  cells in the absence
of cytokines remaining unchanged (results not shown), this
indicated the defect was not associated with a specific mi-
crobial stimulus nor was it due to impaired cytokine re-
sponsiveness. In contrast to p70 expression, the combined
level of p40 and (p40)2 produced by wild-type and c-rel / 
DCs (Fig. 1 B) were equivalent upon SAC activation (Fig.
1 B, lanes 9 and 10) and 50% higher in the c-rel /  cultures1024 c-Rel Regulation of IL-12 p35 Transcription
stimulated with DNA (Fig. 1 B, compare lanes 5 and 6).
The combined p40 and (p40)2 level was also consistently
twofold higher than normal in rela /  DC cultures (Fig. 1
B, lanes 5 and 7; 9 and 11).
Western blotting of culture supernatants fractionated on
nonreducing gels and probed with anti-p40 antibodies (Fig.
2) confirmed the conclusions drawn from the ELISA assays.
Both p40 and p40 homodimer levels secreted by rela / 
(Fig. 2, lane 3) and c-rel /  (Fig. 2, lane 4) DCs were ele-
vated slightly, but normal in nfkb1 /  cells (Fig. 2, lane 2),
whereas IL-12 p70 levels were reduced in nfkb1 /  cul-
tures (Fig. 2, lane 2) and barely detectable in c-rel /  DC
supernatants (Fig. 2, lane 4). The finding that p40 and
(p40)2 levels secreted by activated c-rel /  DCs were similar
to that produced by normal DCs indicated the reduction in
IL-12 expression was not simply an indirect outcome of
decreased c-rel /  DC viability. This conclusion is consis-
tent with our observation that CD11c  DC survival is nor-
mal in the absence of c-Rel (unpublished data).
As the CD8  population is the major source of IL-12 se-
creted by splenic CD11c  DCs (7), a reduction or absence
of CD8  cells was one possible explanation for why IL-12
production by c-rel /  splenic DCs was reduced. This was
addressed by examining the expression of various surface
markers on wild-type and c-rel /  splenic DCs isolated
from naive or FLT3 ligand treated mice. This data, summa-
rized in Fig. 3, shows that the total number and phenotype
of the CD8  DC populations in naive or FLT3 ligand
treated wild-type and c-rel /  mice were indistinguishable.
p40, p70, and (p40)2 production by stimulated FLT3 ligand
treated wild-type and c-rel /  DCs expressing intermediate
(CD8int) or high (CD8hi) levels of CD8 were compared
with the total CD11c  population by Western blot analysis
(Fig. 4). As expected, IL-12 expression in normal splenic
CD11c  DCs was accounted for by the CD8  population
(Fig. 4, lanes 2–4). In the c-rel /  CD8  DCs, IL-12 p70
was absent (Fig. 4, lanes 5 and 6), but p40 and (p40)2 were
present at normal levels (Fig. 4, compare lanes 2, 3, 5, and
6). Collectively these findings indicate that in CD8  DCs,
c-Rel is critical for the expression of IL-12 p70, but not
p40 or (p40)2.
The comparatively normal induction of p40 and (p40)2
expression in c-rel /  DCs in response to SAC or DNA
stimulation contrasted with recent reports showing c-Rel
was essential for LPS-induced p40 expression in macro-
phages (15). To assess if this difference between c-rel / 
Figure 1. Production of IL-12 p70 but not p40 or (p40)2 is markedly
reduced in c-rel /  splenic DCs. (A) IL-12 production by splenic DCs iso-
lated from Rel/NF- B mutant mice. Equivalent numbers of mouse
splenic CD11c  DCs isolated from wild-type (lanes 1, 5, and 9), c-rel / 
(lanes 2, 6, and 10), and nfkb1 /  (lanes 4, 8, and 12) mice or lethally irra-
diated C57BL6Ly5.1  mice reconstituted with E13 rela /  fetal liver cells
(lanes 3, 7, and 11) were cultured in the absence of stimuli (lanes 1–4) or
with either DNA containing CpG motifs (lanes 5–8) or inactivated SAC
(lanes 9–12) in the presence of optimal concentrations of GM-CSF,
IFN- , and IL-4 for 18 h. Supernatants were then assayed for IL-12 p70
content (pg/ml) using a p70-specific ELISA. The error bars represent the
mean   SD within a typical experiment, which was repeated four times
with similar results. ND, refers to “not detectable” below a level of sensi-
tivity of  15 pg/ml. (B) p40 and (p40)2 production by activated CD11c 
splenic DCs lacking different Rel/NF- B proteins. p40 and (p40)2 levels
in culture supernatants described in panel A, were analyzed by p40-spe-
cific ELISA. The combined amount of p40 and (p40)2 was determined by
subtracting the IL-12 p70 reading obtained with the p70 ELISA from val-
ues obtained with the p40 ELISA. The combined level of p40 and (p40)2
(ng/ml) is typical of four independent experiments. The error bars repre-
sent the variation within the experiment. The level of p40/(p40)2 in un-
stimulated DCs (lanes 1–4) was  5 ng/ml.
Figure 2. Western blotting of splenic
DC supernatants. Supernatants from
wild-type (lane 1), nfkb1 /  (lane 2),
rela /  (lane 3), and c-rel /  (lane 4)
CD11c  splenic DCs cultured for 18 h
with SAC plus cytokines were subjected
to nondenaturing electrophoresis and
Western blotting using an anti–IL-12
p40-specific monoclonal antibody. p40,
IL-12 p70, and (p40)2 are indicated. This
result is representative of that obtained
from three independent experiments.1025 Grumont et al.
APCs reflected cell type and/or stimulus specificity, p40/
(p40)2 and p70 IL-12 expression measured by ELISA was
compared in wild-type and c-rel /  CD11c  splenic DCs
stimulated with LPS (Fig. 5). Consistent with previous re-
ports, LPS is a comparatively weak inducer of p40/(p40)2
and IL-12 in wild-type DCs (13), with cytokine levels be-
ing approximately 100-fold lower (Fig. 5, lanes 3 and 7)
than that seen for SAC or DNA stimulated DCs (Fig. 1, A
and B, lanes 5 and 9). Despite the weak induction of p40/
(p40)2 and p70 by LPS, the same pattern of expression was
observed for LPS, SAC, and DNA stimulated c-rel /  DCs.
No IL-12 was detected in LPS stimulated c-rel /  DC cul-
tures (Fig. 5, lane 4), whereas p40/(p40)2 expression was
evident, albeit reduced slightly ( twofold) compared with
wild-type cells (Fig. 5, lanes 4 and 8). These findings indi-
cate that the c-Rel–dependent regulation of p40/(p40)2
expression appears to differ in macrophages and DCs.
In CD8  DCs, c-Rel Is Required for the Induced Expression
of p35 but Not p40. The reduced level of IL-12, but not
p40 or (p40)2 produced by c-rel /  CD8  DC suggested
that this defect may result from impaired p35 expression.
This was assessed by comparing p35 and p40 gene expres-
sion in unstimulated and activated CD8  DCs isolated
from wild-type and Rel/NF- B mutant mice. As IL-12
synthesized by activated CD8  DCs can be detected
within 2 h and reaches steady state levels within 10 h (13),
RNA samples were taken 4 h after stimulation and sub-
jected to Northern blot analysis (Fig. 6 A). Whereas p35
mRNA expression was strongly induced in wild-type cells
upon activation (Fig. 6, lanes 1 and 2), it was barely upreg-
ulated in the stimulated c-rel /  DCs (Fig. 6, lanes 3 and
4). p35 expression was induced in rela /  (Fig. 6 A, lanes 5
and 6) and nfkb1 /  (Fig. 6 A, lanes 7 and 8) DCs, albeit at
Figure 3. Splenic DC development in naive and FLT3 ligand treated
c-rel /  mice is normal. Splenic DCs purified from untreated and FLT3
ligand treated wild-type or c-rel /  mice were stained with monoclonal
antibodies specific for CD8 and CD4, MHC class II, DEC205, or CD11b
and examined by flow cytometry. The data, displayed as contour plots, is
representative of a typical experiment and was repeated three times.
Figure 4. IL-12 production by purified CD8  DCs. Supernatants har-
vested from equivalent numbers of wild-type (lanes 2–4) or c-rel /  (lanes
5–7) CD11c  (lanes 4 and 7), CD8hi (lanes 2 and 5), and CD8int (lanes 3
and 6) splenic DCs stimulated in culture for 18 h, were fractionated on a
non-denaturing acrylamide gel and proteins transferred to nitrocellulose
membranes. p40, p70, and (p40)2 were all detected using an anti-IL-12
p40 monoclonal antibody. Purified p40, p70, and (p40)2 were used as
standards (lane 1).
Figure 5. c-Rel is not essential for LPS induced p40 expression in
CD8  DCs. The level of IL-12 (lanes 1–4) and p40/(p40)2 (lanes 5–8)
production by wild-type (lanes 1, 3, 5, and 7) and c-rel /  (lanes 2, 4, 6,
and 8) splenic DCs without activation (lanes 1, 2, 5, and 6) or upon stim-
ulation with LPS for 18 h was assessed by ELISA. The error bars represent
the mean   SD within a typical experiment, which was repeated twice in
triplicate with similar results. ND is an abbreviation for “not detectable,”
with the limit of sensitivity for the detection of IL-12 p70 at less than 15
pg/ml. p40/(p40)2 levels in unstimulated cells were also below the limit
of detection.1026 c-Rel Regulation of IL-12 p35 Transcription
somewhat reduced levels in cells lacking NF- B1. In con-
trast, p40 mRNA levels were upregulated to the same ex-
tent in normal and c-rel /  CD8  DCs (Fig. 6, lanes 2 and
4). A survey of p40 expression over an 18-h period con-
firmed that the level and induction kinetics of p40 expres-
sion were normal in activated c-rel /  CD8  DC (data not
shown). In the absence of RelA (Fig. 6 A, lanes 5 and 6) or
NF- B1 (Fig. 6 A, lanes 7 and 8), induced p40 mRNA ex-
pression also appeared normal. The LPS-induced expres-
sion of p35 and p40 mRNA was also compared in wild-
type and c-rel /  CD8  DCs (Fig. 6 B). While p35
mRNA levels were rapidly upregulated in response to LPS
in wild-type DCs (Fig. 6, lane 2), it was undetectable in
c-rel /  cells (Fig. 6, lane 4). In contrast, LPS-induced p40
mRNA expression appeared normal in c-rel /  DCs (Fig.
6, compare lanes 2 and 4). These findings indicate that the
impaired induction of IL-12 in activated c-rel /  CD8 
DCs results from an inability to upregulate p35 mRNA
levels and that individually c-Rel, RelA, and NF- B1 are
all dispensable for SAC, LPS, or DNA induced p40 expres-
sion in CD8  DCs.
c-Rel Directly Induces Transcription of the Murine p35
Gene. To determine how c-Rel might regulate p35 gene
expression, we first examined the murine p35 promoter.
Although a putative  B element, 5 -GGGAATCCCT-3 
was located 63 nucleotides upstream of the major transcrip-
tion start site in the sequence determined by Tone et al.
(27), this motif differed in the p35 genomic sequence from
an independent group (34). As both sequences were deter-
mined from C57BL6 mice, ruling out strain-specific poly-
morphisms, we decided to clone and sequence that region
of the promoter encompassing the putative  B element and
found it was identical to that reported by Tone et al. (27).
To establish if the  B-like motif was required for the
c-Rel–dependent induction of p35 transcription, promoter
reporter assays were performed. While macrophage cell
lines such as J774 and W264 had been used successfully for
p40 promoter studies (14, 15), the differences in c-Rel reg-
ulated p40 expression observed in macrophages and DCs
prompted us to compare c-Rel–regulated p35 promoter
function in both cell types. We chose to use J774 cells and
ATL-13, a murine cell line with DC characteristics (30:
unpublished results). The suitability of A7L.13 for this
study was first assessed by examining endogenous p35 and
p40 gene expression in response to LPS or DNA stimula-
tion (Fig. 7 A). In the absence of stimuli, p35 and p40
mRNA levels in A7L.13 cells as measured by semiquantita-
tive reverse transcription PCR were undetectable (Fig. 7
A, lanes 1 and 4), but were induced within 4 h by LPS
(Fig. 7 A, lanes 2 and 5) or DNA (Fig. 7 A, lanes 3 and 6).
As these findings showed p35 expression was upregulated
in A7L.13 cells by c-Rel–dependent stimuli in a manner
similar to that observed in primary CD8  DCs, this cell
line was used for p35 promoter reporter transfections.
A region of the p35 gene that encompassed the putative
 B element, including the 5  untranslated region within
exon 1 and extended 425 nucleotides upstream of the tran-
scriptional start site (see Fig. 7 B) was inserted 5  of the lu-
ciferase gene in the promoterless reporter plasmid, pluc3
(28). This plasmid, designated p35 B-luc, was transiently
transfected into J774 or A7L.13 cells in the absence or pres-
ence of an expression vector encoding c-Rel and the re-
sultant data summarized in Fig. 7 C. The basal promoter
activity (Fig. 7 C, lanes 3 and 9) of p35 B-luc was signifi-
cantly higher than the parental vector (Fig. 7 C, lanes 1, 2,
7, and 8) in both cell lines and was further upregulated
upon co-transfection with an expression vector for c-Rel
(Fig. 7 C, lanes 4 and 10). The role of the putative  B site
was assessed by mutating it to a version (5 -GT-
CAATAACT-3 ) unable to bind Rel/NF- B proteins.
The plasmid, p35 Bm-luc, which contained the mutant
 B site within the context of the full length promoter, re-
tained normal basal promoter activity in A7L.13 cells (Fig.
7 C, lane 11), but was reduced in J774 (Fig. 7 C, lane 5).
Figure 6. p35 but not p40 mRNA expression is markedly reduced in
stimulated c-rel /  CD8  DCs. (A) p35 and p40 mRNA expression in
CD8  DCs from different Rel/NF- B mutant mice. 5  g samples of to-
tal RNA isolated from wild-type (lanes 1 and 2), c-rel /  (lanes 3 and 4),
rela /  (lanes 5 and 6), or nfkb1 /  (lanes 7 and 8) CD8  splenic DCs that
were unstimulated (lanes 1, 3, 5, and 7) or DNA treated (lanes 2, 4, 6, and
8) for 3 h, were analyzed by Northern blot hybridization. Filters were first
hybridized with murine p35 or p40 cDNA probes, then rehybridized
with a rat GAPDH probe. Filters were exposed to autoradiography for
between 24 and 72 h. (B) LPS induced p35 and p40 mRNA expression
in CD8  DCs. 5  g samples of total RNA isolated from wild-type (lanes
1 and 2) and c-rel /  (lanes 3 and 4) DCs that were untreated (lanes 1 and
3) or LPS stimulated (lanes 2 and 4) for 3 h, were analyzed by Northern
blot hybridization as outlined in panel A. Filters were exposed to autora-
diography for 24 h (GAPDH) and 72 h (p35 and p40).1027 Grumont et al.
Moreover, p35 Bm-luc activity was not upregulated by
c-Rel (Fig. 7 C, lanes 6 and 12) in either cell line. The re-
duced  B-dependent basal promoter activity in J774 but
not A7L.13 is consistent with constitutive nuclear Rel/NF-
 B levels being higher in the J774 cells (results not shown).
These results indicate that the  B element within the p35
promoter was necessary and sufficient for Rel/NF- B–
dependent transcription.
Nuclear c-Rel Complexes Induced in Activated CD8  DCs
Bind the  B Element in the p35 Promoter. The binding of
c-Rel complexes to the p35 B site was examined using
electrophoretic mobility shift assays (Fig. 8). Two major
nuclear complexes in unstimulated wild-type (Fig. 8 A,
lane 1) and c-rel /  (Fig. 8 A, lane 3) CD8  DCs, desig-
nated C1 and C2, bound a probe encompassing the
p35 B motif. Within 2 h of DNA or SAC (results not
shown) treatment, a novel nuclear complex (C3) present
in wild-type (Fig. 8 A, lane 2) but not c-rel /  (Fig. 8 A,
lane 4) CD8  DCs, bound the probe, while C2 binding
was reduced. To determine which complexes specifically
bound to the  B site, a probe with the mutant  B motif
(5 -GTCAATAACT-3 ) was used. Whereas the mutant
probe failed to bind the constitutive C1 (Fig. 8 A, lanes
5–8) and inducible C3 complexes seen in wild-type DCs
(Fig. 8 A, lane 6), C2 binding was unaffected in cells of
both genotypes (Fig. 8 A, lanes 5–8). These findings indi-
Figure 7. Functional analysis of the murine p35 promoter. (A) LPS and
DNA induced expression of p35 and p40 in the mouse cell line A7L.13.
Total RNA isolated from A7L.13 cells that were untreated (lanes 1 and 4)
or stimulated with LPS (lanes 2 and 5) or DNA (lanes 3 and 6) for 4 h was
subjected to semiquantitative reverse transcription PCR using p35, p40,
and  -actin–specific primers. PCR products were fractionated on a 1.5%
agarose gel. (B) Schematic representation of the p35 gene 5  flanking re-
gion and luciferase reporter plasmids. The numbers in parenthesis were
assigned according to the transcriptional start site as determined by Tone
et al. (reference 27).The open box represents a putative Rel/NF- B
binding site ( B, 5 -GGGGAATCCCT-3 : 63 to  54), while the cor-
responding symbol with a cross represents the mutated version ( Bm, 5 -
GTCAATAACT-3 ) of this element. The arrow at position 0 denotes the
major transcriptional initiation site. E1 and E2 refer to exons 1 and 2 re-
spectively of the murine p35 gene. The cross-hatched boxes represent 5 -
untranslated sequence in exons 1 and 2, while the filled portion of exon 2
corresponds to coding sequence. The location of the p35 initiation codon
in exon 2 is also shown. The open box designated “luc” refers to the fire-
fly luciferase gene. Plasmid nomenclature is indicated to the right of each
construct. (C) The  B motif in the murine p35 promoter is necessary for
c-Rel–dependent transcription. The J774 and A7L.13 cell lines were each
transiently transfected with 1–2  g of the reporter plasmid pluc (lanes 1,
2, 7, and 8), p35 B-luc (lanes 3, 4, 9, and 10), or p35 Bm-luc (lanes 5, 6,
11, and 12) plus an equimolar amount of ( 10–12  g) of the expression
plasmid DAMP56 with no insert (lanes 1, 3, 5, 7, 9, and 11) or c-Rel
(lanes 2, 4, 6, 8, 10, and 12). The promoter activity measured in extracts
of transfected cells is displayed as relative luciferase units. The results rep-
resent the mean luciferase activity   SD obtained from five separate sets
of transient transfections.1028 c-Rel Regulation of IL-12 p35 Transcription
cated that only C1 and C3 bound the probe via the  B
site.
The composition of C1 and C3 was examined by super-
shift analysis using antibodies specific for different Rel/
NF- B polypeptides (Fig. 8 B). The C3 complex was su-
pershifted with antibodies specific for NF- B1 (Fig. 8 B,
lane 6) and c-Rel (Fig. 8 B, lane 7), but not RelA (Fig. 8
B, lane 8), NF- B2, or Rel B (not shown), demonstrating
that it mainly comprised a c-Rel/NF- B1 heterodimer.
Despite C1 binding being dependent on the p35 B ele-
ment, the mobility of the complex was not typical of a
Rel/NF- B dimer, a conclusion supported by the inabil-
ity of Rel/NF- B–specific antibodies to inhibit its bind-
ing. This is consistent with our preliminary findings that
indicate C1 is an HMG protein (unpublished data). Al-
though C2 does not bind directly to the  B element, in
some experiments C2 binding was reduced by preincubat-
ing with Rel/NF- B–specific antisera. This result, how-
ever, was inconsistent between experiments (Fig. 8 B,
compare lanes 6–8, 13–16). While the basis of this vari-
ability remains unclear, the predicted molecular weight of
the C2 DNA binding protein as determined by cross-link-
ing studies (unpublished data) indicates it is not a Rel/NF-
 B family member.
Discussion
While a considerable amount of information has
emerged on the control of IL-12 p40 gene expression, little
is known about the transcriptional regulation of the p35 lo-
cus. Here we show the Rel/NF- B signaling pathway is
required for the induction of IL-12 in activated CD8 
splenic DCs and the impaired expression of IL-12, but not
p40 or (p40)2 in c-rel /  CD8  DCs is due to an inability to
upregulate p35 transcription which is c-Rel dependent.
Previous studies have established that c-Rel is not essen-
tial for lymphocyte or monocyte development; rather it is
required for a variety of activation associated functions in
mature cells from these lineages such proliferation and cy-
tokine production (20, 35–37). The results presented here
for DCs are consistent with these findings, namely the loss
of c-Rel does not disrupt splenic DC development, but
IL-12 expression by activated CD8  DCs is impaired.
Collectively, these data reinforce the notion that the indis-
pensable roles served by c-Rel in the different hemopoietic
lineages is strictly associated with the regulation of effector
functions in mature cells. In contrast to c-Rel, an absence
of RelB disrupts the differentiation of CD8  myeloid DCs
(38). The separate roles served by these different Rel/NF-
 B proteins during the differentiation and function of DCs
presumably reflects their regulation of distinct genes, a
conclusion consistent with their different binding site spec-
ificity (39) and the inability of c-Rel and RelB to form
heterodimers (40).
A direct association remains to be established between
the impaired expression of IL-12 by c-rel /  APCs and the
immune defects displayed by c-rel /  mice. This issue is
complicated in part by the need to define what role partic-
ular APCs serve during immune responses. Whereas naive
CD8  DCs produce high amounts of IL-12 when activated
(7, 13), macrophages isolated from unprimed mice produce
very low amounts of IL-12 (19). Only in response to prim-
ing “in vivo” under inflammatory conditions or “in vitro”
with GM-CSF, IFN- , and IL-4, are macrophages able to
synthesize high levels of IL-12 (19, 41). Such findings may
indicate that CD8  DCs are the critical source of IL-12
during a primary immune response, while macrophages
could be more important producers of IL-12 later in the
response after adequate priming in the inflammatory milieu
(2, 3, 42). Immune defects arising from the loss of c-Rel
that might be explained in part by a reduction in IL-12 ex-
pression by APCs include the sensitivity of c-rel /  mice to
Leishmania major (36) and the resistance of these mutant
mice to collagen-induced arthritis (43), a disease model in
which IL-12 is known to be important (1).
The data outlined in this paper shows that c-Rel induces
p35 expression in CD8  DCs activated by microbial
agents. The rapid cRel-dependent induction of p35 tran-
scription triggered by LPS, SAC, or DNA is most likely
Figure 8. Rel/NF- B DNA binding activity in DCs. Nuclear extracts
(1–2  g) isolated from purified normal and c-rel /  splenic CD8  DCs
that were unstimulated or activated in culture with DNA for 2 h were in-
cubated with a 32P-radiolabeled p35 B probe, resolved on 5% nondena-
turing polyacrylamide gels, and exposed to autoradiography for 8–24 h at
 70 C. (A) A nuclear complex induced in activated CD8  DCs that
binds the p35 B site is absent in c-rel /  cells. Nuclear extracts from un-
treated (lanes 1, 3, 5, and 7) or activated (lanes 2, 4, 6, and 8) normal
(lanes 1, 2, 5, and 6) and c-rel /  (lanes 3, 4, 7, and 8) DCs were either in-
cubated with a radiolabeled wild-type (lanes 1–4) or mutant (lanes 5–8)
p35 B probe. C1 and C2 represent the fast and slower constitutive com-
plexes respectively, while the inducible complex of slow mobility is des-
ignated C3. (B) The inducible C3 complex is a c-Rel/NF- B1 het-
erodimer. Nuclear extracts from resting (lanes 1–4, 9–12) or activated
(5–8, 13–16) wild-type (lanes 1–8) and c-rel /  (lanes 9–16) DCs were in-
cubated with preimmune (lanes 1, 5, 9, and 13), NF- B1 (lanes 2, 6, 10,
and 14), c-Rel (lanes 3, 7, 11, and 15), or RelA (lanes 4, 8, 12, and 16)-
specific antisera before adding the radiolabeled p35  B probe.1029 Grumont et al.
initiated through mammalian Toll-like receptors (TLRs),
which represent an evolutionarily conserved component of
immunity. For example, in Drosophila, innate immune re-
sponses to microbes are mediated by various antimicrobial
peptides, the expression of which are induced through Toll
signaling by Relish and Dif, the invertebrate counterparts
of Rel/NF- B, (44).
Both cRel and NF- B1, but not RelA are required for
maximal IL-12 expression by CD8  DCs, with their re-
spective contributions to the induction of p70 reflecting
the extent to which these transcription factors regulate p35
expression. The absence of c-Rel resulted in a 30 to 50-
fold decrease in IL-12 levels that coincided with a reduc-
tion of similar magnitude in p35 mRNA. Without NF-
 B1, a reproducible drop of three- to fourfold in both p35
mRNA and IL-12 levels was observed. In contrast, the in-
duced levels of p40 mRNA, p40 monomer, and ho-
modimer made by activated CD8  DCs lacking these tran-
scription factors was unchanged. This shows that in CD8 
DCs, the induction of p70 by Rel/NF- B is regulated
through p35 rather than p40 expression. Consistent with
c-Rel and NF- B1 both being necessary for optimal p35 ex-
pression in CD8  DCs is the finding that NF- B1/c-Rel is
the major induced complex that binds the  B site in the
p35 promoter. c-Rel, however, is the most important of
the dimer partners for p35 expression. Similar findings for
the relative contributions of these subunits in the regulation
of A1 and IRF-4, two genes rapidly induced in activated B
cells (31, 45), reinforces the notion that NF- B1 is mainly
involved in modulating the c-Rel–dependent transcription
of these genes. The p35  B element, 5 -GGGAATCCC-
T-3  is closely related to the sequence 5 -GGGATCC-3 ,
which is conserved within the three functional  B sites
found in the A1 and IRF-4 promoters that bind NF- B1/
c-Rel and c-Rel homodimers (31, 45). The p35 promoter
data reinforces our previous proposal that the sequence 5 -
GGGATCC-3  is a signature for functional  B sites that
preferentially bind these Rel/NF- B dimers (31).
In CD8  DCs, IL-12 p70 expression coincides with a
rapid induction of both p35 and p40 mRNAs in response
to DNA, SAC, LPS, or CD40 (9) stimulation. Although
the coordinated expression of both genes is consistent with
a common mode of transcriptional regulation, p35 but not
p40 transcription was found to depend on c-Rel and NF-
 B1 in these cells. This result was unexpected given a pre-
vious report showing c-Rel was necessary for induced p40
expression in macrophages (15). The most likely explana-
tion for this difference is cell-type specific transcriptional
regulation of p40. If this were the case, it is unlikely that
p40 transcription in CD8  DCs is dependent on another
Rel/NF- B family member such as RelA, an effective ac-
tivator of p40 promoter-reporters (15), as p40 expression
was slightly elevated rather than diminished in rela /  DCs.
Despite c-Rel, RelA, and NF- B1 all being individually
dispensable for p40 expression in CD8  DCs, it remains to
be determined whether this truly reflects Rel/NF- B–
independent regulation of this gene or redundancy amongst
these transcription factors (37). Cell-type–specific regula-
tion of inducible gene expression by c-Rel has been docu-
mented previously for GM-CSF. In T cells, c-Rel is re-
quired for the optimal induction of GM-CSF (35), whereas
it is dispensable for its expression in elicited peritoneal mac-
rophages, and functions as a repressor of GM-CSF tran-
scription in resident peritoneal macrophages (36). Such dif-
ferences seen for both GM-CSF and p40 could be
explained by selective interactions between c-Rel and
other DNA binding proteins or coactivators in the various
cell types. To date the most detailed molecular information
on the role of Rel/NF- B signaling in IL-12 regulation
comes from the study p40 transcription in macrophages
(15). LPS induction of p40 transcription in these cells is de-
pendent upon c-Rel, which is activated through TRL-4
(46). While this requires nucleosome remodeling of the
p40 promoter (46), an event also regulated through this
Toll-like receptor, it is independent of c-Rel and appears
to involve a novel pathway. Ongoing studies aimed at
comparing the role(s) c-Rel serves in determining the
chromatin structure of the p35 and p40 promoters in vari-
ous cell types in response to different stimuli, should in-
crease our understanding of how IL-12 is regulated at the
transcriptional level.
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